Ovid Therapeutics, Inc. (OVID)
2.20
+0.04
(+1.85%)
USD |
NASDAQ |
Apr 02, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Shareholders Equity (Quarterly) : 130.66M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -205.31M |
| CytomX Therapeutics, Inc. | 99.01M |
| Artelo Biosciences, Inc. | -1.272M |
| Eton Pharmaceuticals, Inc. | 26.15M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 150.93M |
| Total Liabilities (Quarterly) | 20.27M |
| Debt to Equity Ratio | 0.1027 |
| Current Ratio | 8.973 |
| Net Debt Paydown Yield | 0.25% |